Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
4(29%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
7%
Ph phase_2
5
36%
Ph phase_3
7
50%

Phase Distribution

0

Early Stage

5

Mid Stage

7

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
5(38.5%)
Phase 3Large-scale testing
7(53.8%)
N/ANon-phased studies
1(7.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

14

all time

Status Distribution
Active(6)
Completed(3)
Other(5)

Detailed Status

unknown5
Completed3
Recruiting3
Not yet recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 25 (38.5%)
Phase 37 (53.8%)
N/A1 (7.7%)

Trials by Status

active_not_recruiting17%
completed321%
not_yet_recruiting214%
recruiting321%
unknown536%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT03201861Phase 3

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Recruiting
NCT06713057Phase 2

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Not Yet Recruiting
NCT05520619Phase 2

Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)

Active Not Recruiting
NCT06588335Phase 2

BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Not Yet Recruiting
NCT04409860Not Applicable

The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer

Recruiting
NCT04138212Phase 3

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

Recruiting
NCT01216111Phase 3

Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)

Completed
NCT03468010Phase 3

A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)

Unknown
NCT02461043Phase 3

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma

Unknown
NCT02133612Phase 2

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma

Completed
NCT01902875

Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy

Unknown
NCT00680940Phase 2

A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer

Completed
NCT01593306Phase 3

Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix

Unknown
NCT00779714Phase 3

Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC

Unknown

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14